Synthetic protein scaffolds based on peptide motifs and cognate adaptor domains for improving metabolic productivity

Frontiers in Bioengineering and Biotechnology

Volumn 3, Issue NOV, 2015, Pages

  Horn, Anselm H C ^a   Sticht, Heinrich ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Adaptor domain; Fusion protein; Linear peptide motif; Metabolic engineering; Protein scaffold

Indexed keywords

AMINO ACIDS; METABOLIC ENGINEERING; METABOLISM; MOLECULES; PEPTIDES; PRODUCTIVITY; SYNTHESIS (CHEMICAL);

ADAPTOR DOMAIN; FUSION PROTEINS; GAMMA-AMINOBUTYRIC ACIDS; LINEAR PEPTIDES; PROTEIN SCAFFOLDS; SIGNALING PATHWAYS; SYNTHETIC BIOLOGY; SYNTHETIC PROTEIN;

SCAFFOLDS (BIOLOGY);

EID: 84983247761     PISSN: None     EISSN: 22964185     Source Type: Journal    
DOI: 10.3389/fbioe.2015.00191     Document Type: Short Survey

References (63)

1. Abdul-Manan, N., Aghazadeh, B., Liu, G. A., Majumdar, A., Ouerfelli, O., Siminovitch, K. A., et al. (1999). Structure of Cdc42 in complex with the GTPase-binding domain of the 'Wiskott-Aldrich syndrome' protein. Nature 399, 379-383. doi: 10.1038/20726
2. Agapakis, C. M., Ducat, D. C., Boyle, P. M., Wintermute, E. H., Way, J. C., and Silver, P. A. (2010). Insulation of a synthetic hydrogen metabolism circuit in bacteria. J. Biol. Eng. 4, 3. doi:10.1186/1754-1611-4-3
3. Amet, N., Lee, H. F., and Shen, W. C. (2009). Insertion of the designed helical linker led to increased expression of tf-based fusion proteins. Pharm. Res. 26, 523-528. doi:10.1007/s11095-008-9767-0
4. Argos, P. (1990). An investigation of oligopeptides linking domains in protein tertiary structures and possible candidates for general gene fusion. J. Mol. Biol. 211, 943-958. doi:10.1016/0022-2836(90)90085-Z
5. Baek, J. M., Mazumdar, S., Lee, S. W., Jung, M. Y., Lim, J. H., Seo, S. W., et al. (2013). Butyrate production in engineered Escherichia coli with synthetic scaffolds. Biotechnol. Bioeng. 110, 2790-2794. doi:10.1002/bit.24925
6. Bai, Y., and Shen, W. C. (2006). Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization. Pharm. Res. 23, 2116-2121. doi:10.1007/s11095-006-9059-5
7. Balla, S., Thapar, V., Verma, S., Luong, T., Faghri, T., Huang, C. H., et al. (2006). Minimotif Miner: a tool for investigating protein function. Nat. Methods 3, 175-177. doi:10.1038/nmeth856
8. Bhattacharyya, R. P., Reményi, A., Yeh, B. J., and Lim, W. A. (2006). Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits. Annu. Rev. Biochem. 75, 655-680. doi:10.1146/annurev.biochem.75.103004.142710
9. Carroll, S. B. (2005). Evolution at two levels: on genes and form. PLoS Biol. 3:e245. doi:10.1371/journal.pbio.0030245
10. Chen, X., Zaro, J. L., and Shen, W. C. (2013). Fusion protein linkers: property, design and functionality. Adv. Drug Deliv. Rev. 65, 1357-1369. doi:10.1016/j.addr.2012.09.039
11. Cheng, H. C., Skehan, B. M., Campellone, K. G., Leong, J. M., and Rosen, M. K. (2008). Structural mechanism of WASP activation by the enterohaemorrhagic E. coli effector EspF(U). Nature 454, 1009-1013. doi:10.1038/nature07160
12. Conrado, R. J., Varner, J. D., and Delisa, M. P. (2008). Engineering the spatial organization of metabolic enzymes: mimicking nature's synergy. Curr. Opin. Biotechnol. 19, 492-499. doi:10.1016/j.copbio.2008.07.006
13. Dinkel, H., and Sticht, H. (2010). "Motif-mediated protein interactions and their role in disease," in Protein-Protein Complexes: Analysis, Modeling and Drug Design, ed. M. Zacharias (London: Imperial College Press), 273-295.
14. Dinkel, H., Van Roey, K., Michael, S., Davey, N. E., Weatheritt, R. J., Born, D., et al. (2014). The eukaryotic linear motif resource ELM: 10 years and counting. Nucleic Acids Res. 42, D259-D266. doi:10.1093/nar/gkt1047
15. Dueber, J. E., Wu, G. C., Malmirchegini, G. R., Moon, T. S., Petzold, C. J., Ullal, A. V., et al. (2009). Synthetic protein scaffolds provide modular control over metabolic flux. Nat. Biotechnol. 27, 753-759. doi:10.1038/nbt.1557
16. Fierer, J. O., Veggiani, G., and Howarth, M. (2014). SpyLigase peptide-peptide ligation polymerizes affibodies to enhance magnetic cancer cell capture. Proc. Natl. Acad. Sci. U.S.A. 111, E1176-E1181. doi:10.1073/pnas.1315776111
17. George, R. A., and Heringa, J. (2002). An analysis of protein domain linkers: their classification and role in protein folding. Protein Eng. 15, 871-879. doi:10.1093/protein/15.11.871
18. Gibson, D. G., Glass, J. I., Lartigue, C., Noskov, V. N., Chuang, R. Y., Algire, M. A., et al. (2010). Creation of a bacterial cell controlled by a chemically synthesized genome. Science 329, 52-56. doi:10.1126/science.1190719
19. Guan, D., Ramirez, M., Shao, L., Jacobsen, D., Barrera, I., Lutkenhaus, J., et al. (2013). Two-component protein hydrogels assembled using an engineered disulfide-forming protein-ligand pair. Biomacromolecules 14, 2909-2916. doi:10.1021/bm400814u
20. Hagemeyer, C. E., von Zur Muhlen, C., von Elverfeldt, D., and Peter, K. (2009). Single-chain antibodies as diagnostic tools and therapeutic agents. Thromb. Haemost. 101, 1012-1019. doi:10.1160/TH08-12-0816
21. Harris, B. Z., and Lim, W. A. (2001). Mechanism and role of PDZ domains in signaling complex assembly. J. Cell. Sci. 114, 3219-3231.
22. Higo, K., Ikura, T., Oda, M., Morii, H., Takahashi, J., Abe, R., et al. (2013). High resolution crystal structure of the Grb2 SH2 domain with a phosphopeptide derived from CD28. PLoS ONE 8:e74482. doi:10.1371/journal.pone.0074482
23. Hulo, N., Sigrist, C. J., Le Saux, V., Langendijk-Genevaux, P. S., Bordoli, L., Gattiker, A., et al. (2004). Recent improvements to the PROSITE database. Nucleic Acids Res. 32, D134-D137. doi:10.1093/nar/gkh044
24. Humphrey, W., Dalke, A., and Schulten, K. (1996). VMD: visual molecular dynamics. J. Mol. Graph. Model. 14, 33-38. doi:10.1016/0263-7855(96)00018-5
25. Huston, J. S., Levinson, D., Mudgett-Hunter, M., Tai, M. S., Novotny, J., Margolies, M. N., et al. (1988). Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 85, 5879-5883. doi:10.1073/pnas.85.16.5879
26. Ishikawa, M., Tsuchiya, D., Oyama, T., Tsunaka, Y., and Morikawa, K. (2004). Structural basis for channelling mechanism of a fatty acid beta-oxidation multienzyme complex. EMBO J. 23, 2745-2754. doi:10.1038/sj.emboj.7600298
27. Ivanova, M. E., Fletcher, G. C., O'reilly, N., Purkiss, A. G., Thompson, B. J., and Mcdonald, N. Q. (2015). Structures of the human Pals1 PDZ domain with and without ligand suggest gated access of Crb to the PDZ peptide-binding groove. Acta Crystallogr. D Biol. Crystallogr. 71, 555-564. doi:10.1107/S139900471402776X
28. Jorgensen, K., Rasmussen, A. V., Morant, M., Nielsen, A. H., Bjarnholt, N., Zagrobelny, M., et al. (2005). Metabolon formation and metabolic channeling in the biosynthesis of plant natural products. Curr. Opin. Plant Biol. 8, 280-291. doi:10.1016/j.pbi.2005.03.014
29. Kim, A. S., Kakalis, L. T., Abdul-Manan, N., Liu, G. A., and Rosen, M. K. (2000). Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature 404, 151-158. doi:10.1038/35004513
30. Koch, C. A., Anderson, D., Moran, M. F., Ellis, C., and Pawson, T. (1991). SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252, 668-674. doi:10.1126/science.1708916
31. Kwok, R. (2010). Five hard truths for synthetic biology. Nature 463, 288-290. doi:10.1038/463288a
32. Kwon, H., Squire, C. J., Young, P. G., and Baker, E. N. (2014). Autocatalytically generated Thr-Gln ester bond cross-links stabilize the repetitive Ig-domain shaft of a bacterial cell surface adhesin. Proc. Natl. Acad. Sci. U.S.A. 111, 1367-1372. doi:10.1073/pnas.1316855111
33. Li, J., Nayak, S., and Mrksich, M. (2010). Rate enhancement of an interfacial biochemical reaction through localization of substrate and enzyme by an adaptor domain. J. Phys. Chem. B 114, 15113-15118. doi:10.1021/jp102820e
34. Li, L., Fierer, J. O., Rapoport, T. A., and Howarth, M. (2014). Structural analysis and optimization of the covalent association between SpyCatcher and a peptide Tag. J. Mol. Biol. 426, 309-317. doi:10.1016/j.jmb.2013.10.021
35. Lu, P., and Feng, M. G. (2008). Bifunctional enhancement of a beta-glucanase-xylanase fusion enzyme by optimization of peptide linkers. Appl. Microbiol. Biotechnol. 79, 579-587. doi:10.1007/s00253-008-1468-4
36. Lu, Y., Huang, F., Wang, J., and Xia, J. (2014). Affinity-guided covalent conjugation reactions based on PDZ-peptide and SH3-peptide interactions. Bioconjug. Chem. 25, 989-999. doi:10.1021/bc500134w
37. Luo, Y., Lee, J. K., and Zhao, H. (2013). Challenges and opportunities in synthetic biology for chemical engineers. Chem. Eng. Sci. 103:115-9. doi:10.1016/j.ces.2012.06.013
38. Machida, K., and Mayer, B. J. (2005). The SH2 domain: versatile signaling module and pharmaceutical target. Biochim. Biophys. Acta 1747, 1-25. doi:10.1016/j.bbapap.2004.10.005
39. Martin, V. J., Pitera, D. J., Withers, S. T., Newman, J. D., and Keasling, J. D. (2003). Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat. Biotechnol. 21, 796-802. doi:10.1038/nbt833
40. Mayer, B. J. (2001). SH3 domains: complexity in moderation. J. Cell. Sci. 114, 1253-1263.
41. McEntyre, J. R., and Gibson, T. J. (2004). Patterns and clusters within the PSM column in TiBS, 1992-2004. Trends Biochem. Sci. 29, 627-633. doi:10.1016/j.tibs.2004.10.006
42. Miles, E. W., Rhee, S., and Davies, D. R. (1999). The molecular basis of substrate channeling. J. Biol. Chem. 274, 12193-12196. doi:10.1074/jbc.274.18.12193
43. Moon, T. S., Dueber, J. E., Shiue, E., and Prather, K. L. (2010). Use of modular, synthetic scaffolds for improved production of glucaric acid in engineered E. coli. Metab. Eng. 12, 298-305. doi:10.1016/j.ymben.2010.01.003
44. Moon, T. S., Yoon, S. H., Lanza, A. M., Roy-Mayhew, J. D., and Prather, K. L. (2009). Production of glucaric acid from a synthetic pathway in recombinant Escherichia coli. Appl. Environ. Microbiol. 75, 589-595. doi:10.1128/AEM.00973-08
45. Nakamura, C. E., and Whited, G. M. (2003). Metabolic engineering for the microbial production of 1,3-propanediol. Curr. Opin. Biotechnol. 14, 454-459. doi:10.1016/j.copbio.2003.08.005
46. Pawson, T., Gish, G. D., and Nash, P. (2001). SH2 domains, interaction modules and cellular wiring. Trends Cell Biol. 11, 504-511. doi:10.1016/S0962-8924(01)02154-7
47. Pfeifer, B. A., and Khosla, C. (2001). Biosynthesis of polyketides in heterologous hosts. Microbiol. Mol. Biol. Rev. 65, 106-118. doi:10.1128/MMBR.65.1.106-118.2001
48. Ro, D. K., Paradise, E. M., Ouellet, M., Fisher, K. J., Newman, K. L., Ndungu, J. M., et al. (2006). Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440, 940-943. doi:10.1038/nature04640
49. Robinson, C. R., and Sauer, R. T. (1998). Optimizing the stability of single-chain proteins by linker length and composition mutagenesis. Proc. Natl. Acad. Sci. U.S.A. 95, 5929-5934. doi:10.1073/pnas.95.11.5929
50. Saksela, K., and Permi, P. (2012). SH3 domain ligand binding: what's the consensus and where's the specificity? FEBS Lett. 586, 2609-2614. doi:10.1016/j.febslet.2012.04.042
51. Schultz, J., Hoffmüller, U., Krause, G., Ashurst, J., Macias, M. J., Schmieder, P., et al. (1998). Specific interactions between the syntrophin PDZ domain and voltage-gated sodium channels. Nat. Struct. Biol. 5, 19-24. doi:10.1038/nsb0198-19
52. Schweimer, K., Hoffmann, S., Bauer, F., Friedrich, U., Kardinal, C., Feller, S. M., et al. (2002). Structural investigation of the binding of a herpesviral protein to the SH3 domain of tyrosine kinase Lck. Biochemistry 41, 5120-5130. doi:10.1021/bi015986j
53. Songyang, Z., Fanning, A. S., Fu, C., Xu, J., Marfatia, S. M., Chishti, A. H., et al. (1997). Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science 275, 73-77. doi:10.1126/science.275.5296.73
54. Spivey, H. O., and Ovadi, J. (1999). Substrate channeling. Methods 19, 306-321. doi:10.1006/meth.1999.0858
55. Takamatsu, N., Watanabe, Y., Yanagi, H., Meshi, T., Shiba, T., and Okada, Y. (1990). Production of enkephalin in tobacco protoplasts using tobacco mosaic virus RNA vector. FEBS Lett. 269, 73-76. doi:10.1016/0014-5793(90)81121-4
56. Veggiani, G., Zakeri, B., and Howarth, M. (2014). Superglue from bacteria: unbreakable bridges for protein nanotechnology. Trends Biotechnol. 32, 506-512. doi:10.1016/j.tibtech.2014.08.001
57. Vo, T. D. L., Ko, J. S., Park, S. J., Lee, S. H., and Hong, S. H. (2013). Efficient gamma-aminobutyric acid bioconversion by employing synthetic complex between glutamate decarboxylase and glutamate/GABA antiporter in engineered Escherichia coli. J. Ind. Microbiol. Biotechnol. 40, 927-933. doi:10.1007/s10295-013-1289-z
58. Wang, Y., and Yu, O. (2012). Synthetic scaffolds increased resveratrol biosynthesis in engineered yeast cells. J. Biotechnol. 157, 258-260. doi:10.1016/j.jbiotec.2011.11.003
59. Welch, G. R., and Gaertner, F. H. (1980). Enzyme organization in the polyaromatic-biosynthetic pathway: the arom conjugate and other multienzyme systems. Curr. Top. Cell. Regul. 16, 113-162. doi:10.1016/B978-0-12-152816-4.50009-1
60. Werner, S., Marillonnet, S., Hause, G., Klimyuk, V., and Gleba, Y. (2006). Immunoabsorbent nanoparticles based on a Tobamovirus displaying protein A. Proc. Natl. Acad. Sci. U.S.A. 103, 17678-17683. doi:10.1073/pnas.0608869103
61. Zakeri, B., Fierer, J. O., Celik, E., Chittock, E. C., Schwarz-Linek, U., Moy, V. T., et al. (2012). Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin. Proc. Natl. Acad. Sci. U.S.A. 109, E690-E697. doi:10.1073/pnas.1115485109
62. Zhao, H. L., Yao, X. Q., Xue, C., Wang, Y., Xiong, X. H., and Liu, Z. M. (2008). Increasing the homogeneity, stability and activity of human serum albumin and interferon-alpha2b fusion protein by linker engineering. Protein Expr. Purif. 61, 73-77. doi:10.1016/j.pep.2008.04.013
63. Zhao, S., Jones, J. A., Lachance, D. M., Bhan, N., Khalidi, O., Venkataraman, S., et al. (2015). Improvement of catechin production in Escherichia coli through combinatorial metabolic engineering. Metab. Eng. 28, 43-53. doi:10.1016/j.ymben.2014.12.002